A detailed history of Bell Investment Advisors, Inc transactions in Morpho Sys Ag stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 39 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Holding current value
$0
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$17.36 - $19.34 $677 - $754
39 New
39 $0
Q3 2023

Nov 08, 2023

BUY
$6.72 - $8.6 $631 - $808
94 Added 142.42%
160 $1,000
Q2 2023

Aug 09, 2023

BUY
$3.95 - $7.74 $260 - $510
66 New
66 $0

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.